Arrowhead Pharmaceuticals (ARWR) EPS (Basic) (2010 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly EPS (Basic) came in at -$0.97 in Q1 2026, down 135.02% YoY from $2.76 in Q1 2025, and down 568.72% on a QoQ basis from $0.21 in Q4 2025.
Arrowhead Pharmaceuticals (ARWR) EPS (Basic) (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 17 years of EPS (Basic) data on file, last reported at -$0.97 in Q1 2026.
- Quarterly EPS (Basic) fell 135.02% year-over-year to -$0.97 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.91 (down 64.62% YoY) and the FY2025 annual result came in at $0.23, up 104.42% from the prior year.
- EPS (Basic) retreated to -$0.97 in Q1 2026, from $0.21 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.76 in Q1 2025 to a low of -$1.45 in Q3 2024.
- A 5-year average of -$0.51 and a median of -$0.97 in 2026 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) sank 330.66% — and 2025, when it jumped 367.78%.
- Tracing ARWR's EPS (Basic) over 5 years: stood at -$0.39 in 2022, then slumped by 219.76% to -$1.26 in 2023, then dropped by 11.36% to -$1.4 in 2024, then jumped by 114.68% to $0.21 in 2025, then tumbled by 568.72% to -$0.97 in 2026.
- The last three EPS (Basic) figures came in at -$0.97 (Q1 2026), $0.21 (Q4 2025), and $0.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Arrowhead Pharmaceuticals | 12.23 Bn | 10.63 Bn | - | -1.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25 |
| Mar 31, 2026 | -0.97 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | -1.29 |
| Mar 31, 2025 | 2.76 |
| Dec 31, 2024 | -1.40 |
| Sep 30, 2024 | -1.45 |
| Jun 30, 2024 | -1.40 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -1.26 |
| Sep 30, 2023 | -1.04 |
| Jun 30, 2023 | -0.97 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.82 |
| Jun 30, 2022 | -0.68 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.61 |